Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 8Lymphoid 6Other hematologic neoplasm 3Classical hematology 2Sarcoma 1Other solid neoplasm 1Head & Neck 1Endocrine 1

Conditions

Sarcoma 436Osteosarcoma 134Sarcoma, Ewing 89Melanoma 81Rhabdomyosarcoma 78Neoplasms 71Gastrointestinal Stromal Tumors 63Neuroblastoma 62Bone Neoplasms 62Colorectal Neoplasms 61Breast Neoplasms 60Ovarian Neoplasms 58Glioblastoma 55Neoplasm Metastasis 52Liposarcoma 50Dendritic Cell Sarcoma, Interdigitating 45Carcinoma, Non-Small-Cell Lung 44Leiomyosarcoma 43Gliosarcoma 42Stomach Neoplasms 41Pancreatic Neoplasms 41Lymphoma 37Sarcoma, Synovial 35Glioma 35Carcinoma, Renal Cell 35Uterine Cervical Neoplasms 34Rhabdoid Tumor 34Neurofibrosarcoma 34Lung Neoplasms 34Sarcoma, Kaposi 33

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphohistiocytosis, Hemophagocytic × Sarcoma × 1 year × Clear all
NCT00710892 2025-07-11

CASPALLO

Baylor College of Medicine

Phase 1 Active not recruiting
10 enrolled
LymphoidMyeloidOther hematologic neoplasmSarcoma

Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Lymphohistiocytosis, Hemophagocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Histiocytic Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡